|
|
|
|
| LEADER |
00806nab a2200205 i 4500 |
| 001 |
publ851 |
| 005 |
20180723102020.0 |
| 008 |
120706s2011 hu o 0|| zxx d |
| 022 |
|
|
|a 0363-9045
|
| 024 |
7 |
|
|a 10.3109/03639045.2011.569933
|2 doi
|
| 024 |
7 |
|
|a 1969716
|2 mtmt
|
| 040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
| 041 |
|
|
|a zxx
|
| 100 |
2 |
|
|a Jójártné Laczkovich Orsolya
|
| 245 |
1 |
0 |
|a Formulation of tablets containing an ‘in-process’ amorphized active pharmaceutical ingredient
|h [elektronikus dokumentum] /
|c Jójártné Laczkovich Orsolya
|
| 260 |
|
|
|a Informa Healthcare
|c 2011
|
| 300 |
|
|
|a 1272-1281
|
| 490 |
0 |
|
|a Drug Development and Industrial Pharmacy
|v 37 No. 11
|
| 700 |
0 |
1 |
|a Révész Piroska
|e aut
|
| 856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/851/1/Drug_Dev._Ind._Pharm..pdf
|z Dokumentum-elérés
|